During the last session, AnaptysBio Inc (NASDAQ:ANAB)’s traded shares were 0.48 million, with the beta value of the company hitting 0.02. At the end of
During the last session, Harvard Bioscience Inc (NASDAQ:HBIO)’s traded shares were 0.43 million, with the beta value of the company hitting 1.24. At the end
During the last session, 22nd Century Group Inc (NASDAQ:XXII)’s traded shares were 0.34 million, with the beta value of the company hitting 1.59. At the
During the last session, 180 Life Sciences Corp (NASDAQ:ATNF)’s traded shares were 0.41 million. At the end of the trading day, the stock’s price was
During the last session, Matinas Biopharma Holdings Inc (AMEX:MTNB)’s traded shares were 0.87 million, with the beta value of the company hitting 1.61. At the
During the last session, Valens Semiconductor Ltd (NYSE:VLN)’s traded shares were 0.58 million, with the beta value of the company hitting 0.36. At the end
During the last session, Myomo Inc (AMEX:MYO)’s traded shares were 0.33 million, with the beta value of the company hitting 1.67. At the end of
During the last session, Silence Therapeutics Plc ADR (NASDAQ:SLN)’s traded shares were 0.39 million, with the beta value of the company hitting 1.01. At the
During the last session, Nu Skin Enterprises, Inc (NYSE:NUS)’s traded shares were 0.36 million, with the beta value of the company hitting 1.17. At the
During the last session, UTime Ltd (NASDAQ:WTO)’s traded shares were 0.62 million, with the beta value of the company hitting 0.59. At the end of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
